Company Filing History:
Years Active: 2022-2024
Title: Innovations of Inventor Ling Leung
Introduction
Ling Leung is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody therapies. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Ling Leung's latest patents focus on triple combination antibody therapies. These innovative therapies involve the use of anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies. This combination aims to enhance the effectiveness of cancer treatments by targeting multiple pathways simultaneously.
Career Highlights
Ling Leung is currently employed at Compugen Ltd. Corporation, where he continues to push the boundaries of medical research and innovation. His work is instrumental in developing new therapeutic strategies that could potentially improve patient outcomes in oncology.
Collaborations
Some of Ling's coworkers include Spencer Liang and Sarah Whelan, who contribute to the collaborative environment that fosters innovation at Compugen. Their combined expertise enhances the research and development efforts within the company.
Conclusion
Ling Leung's contributions to the field of biotechnology through his innovative patents and collaborative work at Compugen Ltd. Corporation highlight his role as a leading inventor in the industry. His research on triple combination antibody therapies represents a significant step forward in cancer treatment.